/

Cresilon

Develops plant-based hemostatic gels to stop bleeding instantly.

BiotechnologyMedical Devices cresilon.com ↗

Company facts

Founded: 2010
Employees: 93
Headquarters: United States
Type: Private
Funding: Series B · $113M · 2025